<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03069924</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00055397</org_study_id>
    <nct_id>NCT03069924</nct_id>
  </id_info>
  <brief_title>Gain-framed Messages and NRT for Lung Cancer Screening Patients</brief_title>
  <official_title>Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is a randomized smoking cessation trial conducted within and specifically
      personalized for lung cancer screening patients presenting to a lung screening clinic. Novel
      tobacco treatments for this population are critically needed, given the growing population of
      lung screening patients, which will grow dramatically now that lung screening is an approved
      CMS benefit. In the proposed study, we will test a gain-framed messaging intervention
      specifically designed for lung screening patients (vs. unframed messaging), as well as
      evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be
      translational (in that it can be transferable from our controlled efficacy study to other
      lung screening programs).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking cessation rates</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>NRT+Gain-framed messaging vs. no NRT-no messaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation rates</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>NRT+Gain-framed messaging vs. NRT-no messaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation rates</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>No NRT-Gain-framed messaging vs. No NRT-no messaging</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">616</enrollment>
  <condition>Lung Cancer Screening</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>No NRT - No Messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brief counseling, but no NRT and no gain-framed messaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NRT - No Messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brief counseling plus NRT but no gain-framed messaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No NRT - Messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brief counseling plus gain-framed messaging but no NRT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NRT plus Messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brief counseling plus NRT and gain-framed messaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Gain-framed messaging</intervention_name>
    <description>counseling plus gain-framed messaging</description>
    <arm_group_label>No NRT - Messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine replacement therapy</intervention_name>
    <description>counseling plus NRT</description>
    <arm_group_label>NRT - No Messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Gain-framed messaging plus NRT</intervention_name>
    <description>counseling plus gain-framed messaging and NRT</description>
    <arm_group_label>NRT plus Messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counseling alone</intervention_name>
    <description>Counseling only</description>
    <arm_group_label>No NRT - No Messaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 55 years or older

          2. 30 pack year history of smoking

          3. current smoker (defined as any smoking in the past 30 days)

          4. willing to be randomized

          5. English speaking

        Exclusion Criteria:

          1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis,
             severe alcohol dependence, or dementia,

          2. known allergy to adhesives

          3. being in the immediate (within 2 weeks) post myocardial infarction period

          4. serious arrhythmias

          5. unstable angina pectoris

          6. hemodynamically or electrically unstable.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Toll, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alana Rojewski, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Toll, PhD</last_name>
    <phone>843-876-1132</phone>
    <email>toll@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nortorious Coleman-Taylor</last_name>
    <phone>843-509-7589</phone>
    <email>colemann@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yale Cancer Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bennie Ford</last_name>
      <email>bennie.ford@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Fucito, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nortorious Coleman-Taylor</last_name>
      <email>colemann@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Benjamin Toll, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>September 29, 2017</last_update_submitted>
  <last_update_submitted_qc>September 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

